8-KThe WireRoutine
Shareholder Vote
Filed Jun 10, 2026 · 19d ago · Accession 0001326110-26-000064
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- ImmunityBio, Inc.
- Ticker
- IBRX
- CIK
- 1326110
- Form type
- 8-K
- Filing date
- Jun 10, 2026
- Report date
- Jun 9, 2026
- Document
- ibrx-20260609.htm
- Size
- 159 KB